1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Development of cell assays for exploration of novel immunotherapeutic drugs for cancer treatment
- Master (Two yrs)
-
Mark
Investigation of treatment-guiding gene signatures in cancer using RNA-sequencing data
- Master (Two yrs)
- 2022
-
Mark
Biophysical analysis of Immunotherapy and Cancer modeling
(2022) FYTM03 20221
Computational Biology and Biological Physics - Has been reorganised
Department of Astronomy and Theoretical Physics - Has been reorganised- Master (Two yrs)
- 2021
-
Mark
Formulation development of a recombinant VAR2-antiCD3 protein for cancer immunotherapy
- Master (Two yrs)
- 2020
-
Mark
Studying the Whole Through the Sum of its Parts: Comparing CD8+ Tumour Infiltrating Lymphocytes in Three Types of Human Carcinoma
- Bach. Degree
- 2019
-
Mark
Competitive Intelligence in Immuno-Oncology
- Master (Two yrs)
- 2017
-
Mark
Discovery of antibodies targeting the immune checkpoint protein PD-L1
- Master (Two yrs)
- 2015
-
Mark
Generation and characterization of antibody fragments against a receptor expressed on regulatory T cells
- Master (Two yrs)
-
Mark
Pattern recognition receptors’ and chemokine receptor expression on tonsil dendritic cells
- Master (Two yrs)
- 2014
-
Mark
A model for immunotherapies against small, solid and motile tumors
(2014) FYSM31 20132
Department of Physics
Computational Biology and Biological Physics - Has been reorganised- Master (Two yrs)